Sam Mbulaiteye | |
|---|---|
 | |
| Alma mater | Makerere University University of Cambridge |
| Scientific career | |
| Fields | Cancer epidemiology |
| Institutions | National Cancer Institute |
Sam M. Mbulaiteye is a Ugandan physician-scientist and epidemiologist who researches Burkitt lymphoma. He is a senior investigator at the National Cancer Institute.
Mbulaiteye received physician training at Makerere University (1990) with advanced training in epidemiology and biostatistics (M.Phil.) from the University of Cambridge (1994), and specialist training in internal medicine (M.Med.) from Makerere University (1996). [1] His early research focused on measuring the impact of HIV on cancer in patients at the Uganda Cancer Institute from 1994 and 1997 and investigating population trends of HIV in a general population in rural southwest Uganda while at the Uganda Virus Research Institute and U.K. Medical Research Council HIV program. [1]
In December 2000, Mbulaiteye joined National Cancer Institute's (NCI) infections and immunoepidemiology branch (IIB) to focus his work on KS and Burkitt lymphoma (BL) as a research fellow, and was awarded NIH scientific tenure and appointed senior investigator in 2013. [1] He conducts research to understand the etiology of BL. [1] Mbulaiteye is the co-editor-in-chief of Infectious Agents and Cancer . [1] [2]
The Wistar Institute is an independent, nonprofit research institution in biomedical science with special focuses in oncology, immunology, infectious disease, and vaccine research. Located on Spruce Street in the University City section of Philadelphia, Wistar was founded in 1892 as a nonprofit institution to focus on biomedical research and training.
Uganda Cancer Institute (UCI) is a public, specialized, tertiary care medical facility owned by the Uganda Ministry of Health. It is designated as East Africa's Centre of Excellence in Oncology. In collaboration with Makerere University College of Health Sciences, UCI plans to start offering master's degrees, doctoral programs and post-doctoral fellowships in oncology care.
Elaine Sarkin Jaffe is a senior National Cancer Institute (NCI) investigator at the National Institutes of Health (NIH) most well known for her contribution to hematopathology. She completed her medical education at Cornell University and the University of Pennsylvania, receiving her M.D. degree from University of Pennsylvania in 1969. After an internship at Georgetown University she joined NCI as a resident in anatomic pathology, and has been a senior investigator since 1974, focusing on the classification and definition of lymphomas. Jaffe's early work helped to provide a deeper understanding of the origin of lymphomas, especially follicular lymphoma. Her team notably elucidated the difference between T cell and B cell lymphomas.
Christine Campo Alewine is an American oncologist and biologist researching immunotoxin therapeutics in pancreatic cancer. She is an investigator at the National Cancer Institute.
Deborah E. Citrin is an American clinician-scientist researching pre-clinical and clinical testing of radiation modifiers and the mechanisms of normal tissue injury from radiation. She is a senior investigator and deputy director of the National Cancer Institute's Center for Cancer Research.
Wei-Shau Hu is an American geneticist specialized in HIV research, retroviral recombination, RNA packaging, and virus assembly. She is a senior investigator at the National Cancer Institute and head of the viral recombination section. She was an associate professor at West Virginia University.
Susan Marie Mackem is an American anatomic pathologist and physician-scientist. She researches vertebrate primary axis formation and the regulation of patterning and differentiation during limb development. She is a senior investigator and head of the regulation of vertebrate morphogenesis section at the National Cancer Institute's Frederick National Laboratory for Cancer Research. She is also an attending pathologist at the National Institutes of Health Clinical Center.
Nirali N. Shah is an American physician-scientist and pediatric hematologist-oncologist, serving as head of the hematologic malignancies section of the pediatric oncology branch at the National Cancer Institute. She researches the translation of immunotherapeutic approaches to treat high-risk hematologic malignancies in children, adolescents and young adults.
Jacqueline Jia-Kang Whang-Peng is a Taiwanese-American physician-scientist specialized in cytogenetics of cancer, as well as medical genetics, genetic oncology, and gene mapping. She was a researcher at the National Cancer Institute from 1960 to 1993.
Xiaohong Rose Yang is an American biomedical scientist researching the genetics of dysplastic nevus syndrome and chordoma, and etiologic heterogeneity of breast cancer. She is a senior investigator at the National Cancer Institute. Yang leads breast cancer studies in mainland China, Hong Kong, and Malaysia.
Rachael Zoe Stolzenberg-Solomon is an American epidemiologist and dietitian. She is a senior investigator and head of the metabolic epidemiology branch at the National Cancer Institute.
Mitchell H. Gail is an American physician-scientist and biostatistician. He is a distinguished investigator at the National Cancer Institute.
Shahinaz Mohamed Aly Gadalla is a physician-scientist and cancer epidemiologist who researches cancer biomarkers and hematopoietic stem cell transplantation. She is a senior investigator in the clinical genetics branch at the National Cancer Institute.
Neelam K. Giri is an Indian pediatric hematologist/oncologist and physician-scientist who researches bone marrow failure syndromes. She is a staff clinician in the clinical genetics branch at the National Cancer Institute.
Jill E. Koshiol is an American cancer epidemiologist who researches the risk factors of hepatobiliary cancers. She is a senior investigator in the infections and immunoepidemiology branch at the National Cancer Institute.
Meredith Sarah Shiels is an American cancer epidemiologist who researches cancer risks in people with HIV. She is a senior investigator at the National Cancer Institute.
Sonja Ingrid Berndt is an American pharmacologist and cancer epidemiologist who researches non-Hodgkin lymphoma, prostate cancer, and anthropometric traits that are cancer risk factors. She is a senior investigator in the occupational and environmental epidemiology branch at the National Cancer Institute.
Qing Lan is a Chinese physician-scientist and molecular epidemiologist who researches indoor air pollution, lung cancer, and occupational exposures. She is a senior investigator in the occupational and environmental epidemiology branch at the National Cancer Institute.
Lindsay McOmber Morton is an American cancer epidemiologist who researches genetic susceptibility to second cancers. She is the Director of the radiation epidemiology branch and head of its cancer survivorship research unit at the National Cancer Institute.
Jonine Figueroa is an American epidemiologist specializing in breast cancer epidemiology. She is a senior investigator and distinguished scholar in the integrative tumor epidemiology branch at the National Cancer Institute. She was previously a tenured professor and chair of molecular epidemiology and global cancer prevention at the University of Edinburgh.
This article incorporates text from this source, which is in the public domain . This article incorporates public domain material from websites or documents of the National Institutes of Health.| International | |
|---|---|
| National | |
| Academics | |
  | This Ugandan biographical article related to medicine is a stub. You can help Wikipedia by expanding it. |
